Actualités Intercure Ltd - INCR.U | Actions Toronto Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

InterCure Provides an Update Regarding the Security Situation in Israel

NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR...

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Achieved record revenues of NIS 209 million ($75 million)1 for the first half of 2023 Annualized revenue run...

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

NEW YORK and TORONTO and HERZLIYA, Israel, July 10, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX:...

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million...

InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business

NEW YORK and TORONTO and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: INCR) (TSX: INCR.U...

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

NEW YORK and TORONTO and HERZLIYA, Israel, April 25, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

NEW YORK, TORONTO, and HERZLIYA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercure Ltd (INCR.U)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

INCR.U Actualités

InterCure Provides an Update Regarding the Security Situation in Israel

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

InterCure Reschedules 2022 Full Year Results Conference Call

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intercure Ltd (INCR.U) Actualités

Intercure Ltd (INCR.U)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

INCR.U Actualités

InterCure Provides an Update Regarding the Security Situation in Israel

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

InterCure Reschedules 2022 Full Year Results Conference Call

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application